Protara trumpets small rare disease dataset in children for cell therapy

Protara Therapeutics on Wednesday revealed new data showing its experimental bladder cancer cell therapy could also have potential in a rare pediatric disease. In a small, open-label Phase 2 dataset, Protara’s TARA-002